Increase of platelet thromboxane A2 formation and of its plasmatic half-life in diabetes mellitus.
D000328:Adult; D000368:Aged; D001095:Arachidonic Acids / Q000494:pharmacology; D001792:Blood Platelets / Q000503:physiopathology*; D003094:Collagen / Q000494:pharmacology; D003920:Diabetes Mellitus / Q000097:blood*; D005230:Fatty Acids, Nonesterified / Q000097:blood; D005260:Female; D006207:Half-Life; D006801:Humans; D008297:Male; D008875:Middle Aged; D010974:Platelet Aggregation; D011453:Prostaglandins / Q000096:biosynthesis; D013928:Thromboxane A2 / Q000096:biosynthesis* / Q000097:blood; D013929:Thromboxane B2 / Q000096:biosynthesis; D013931:Thromboxanes / Q000096:biosynthesis*
D001095:Arachidonic Acids; D005230:Fatty Acids, Nonesterified; D011453:Prostaglandins; D013931:Thromboxanes; D013929:Thromboxane B2; D013928:Thromboxane A2; D003094:Collagen